Globe Life Inc (GL) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 3, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 5, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the GL SEC filings page.
Globe Life Inc (GL) reported $6.2B in revenue over the twelve months to Jun 30, 2026, up 5.2% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Globe Life’s dominant mechanic is steady cash generation paired with substantial share reduction, while reinvestment increasingly absorbs more of that cash.
Operating cash flow remained near$1.4B from FY2023 through FY2025, yet free cash flow weakened as capital expenditures rose sharply; the business remains cash generative, but less cash is discretionary after reinvestment. That cash-conversion divergence points to a rising reinvestment burden rather than deterioration in day-to-day cash production.
The balance sheet became larger without a matching leverage surge: total assets rose while debt-to-equity stayed below 0.5x. That combination suggests growth has been funded more by accumulated equity and operating earnings than by borrowing alone.
Share count fell materially from FY2021 to FY2025 while net income increased only moderately, so the much faster rise in per-share earnings reflects both business earnings and a smaller denominator. This makes capital allocation a major contributor to reported per-share growth, not merely an afterthought.
Financial Health Signals
Scored against insurers for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Globe Life Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Loss Ratio measures the claims an insurer paid out against the premiums it earned, so a lower ratio leaves more of every premium dollar with the company. Globe Life Inc scores 57/100 on it among other insurers.
Not available for Globe Life Inc, and counted as zero in the overall score.
Globe Life Inc funded 19.4% of its assets with shareholders' equity at the end of fiscal year 2025, holding $6.0B of equity against $30.8B of assets. Capital ranks insurers on that cushion, and Globe Life Inc scores 34/100 among other insurers.
Not available for Globe Life Inc, and counted as zero in the overall score.
Combined Ratio puts claims and running costs together against premiums earned, and a figure under 100% means the underwriting made money before any investment income was counted. Globe Life Inc scores 68/100 on it among other insurers.
Globe Life Inc reported net income of $1.2B in fiscal year 2025, against $1.1B in fiscal year 2024. Stability ranks insurers on how steady net income has been across five years, and Globe Life Inc scores 98/100 among other insurers.
Globe Life Inc passes 6 of 7 computable financial strength tests (2 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), all 2 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, Globe Life Inc generates $1.20 in operating cash flow ($1.4B OCF vs $1.2B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Key Financial Metrics
Earnings & Revenue
Globe Life Inc generated $1.6B in revenue in Q2 2026. This represents an increase of 8.0% from the same quarter a year earlier. Against the prior quarter it is up 2.6%.
Globe Life Inc reported $287.7M in net income in Q2 2026. This represents an increase of 13.8% from the same quarter a year earlier. Against the prior quarter it is up 6.4%.
Globe Life Inc earned $3.65 per diluted share (EPS) in Q2 2026. This represents an increase of 19.7% from the same quarter a year earlier. Against the prior quarter it is up 7.7%.
Not reported for Q2 2026.
Cash & Balance Sheet
Globe Life Inc generated $297.6M in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 0.9% from the same quarter a year earlier. Against the prior quarter it is down 24.9%.
Globe Life Inc held $257.1M in cash against $2.7B in long-term debt as of Q2 2026.
Globe Life Inc paid $0.33 per share in dividends in Q2 2026. This represents an increase of 22.2% from the same quarter a year earlier. It is unchanged from the prior quarter.
Margins & Returns
Globe Life Inc's net profit margin was 18.0% in Q2 2026, showing the share of revenue converted to profit. This is up 0.9 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.6 percentage points.
Globe Life Inc's ROE was 4.7% in Q2 2026, measuring profit generated per dollar of shareholder equity. That is unchanged from the same quarter a year earlier. Against the prior quarter it is up 0.2 percentage points.
Not reported for Q2 2026.
Not reported for Q2 2026.
Capital Allocation
Globe Life Inc spent $274.7M on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. This represents an increase of 9.8% from the same quarter a year earlier. Against the prior quarter it is up 14.2%.
Globe Life Inc invested $16.5M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 27.5% from the same quarter a year earlier. Against the prior quarter it is down 33.8%.
Not reported for Q2 2026.
GL Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.6B+8.0% | $1.6B+5.3% | $1.5B+3.6% | $1.5B+4.0% | $1.5B+2.8% | $1.5B+4.5% | $1.5B+3.6% | $1.5B+5.2% |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $379.1M+18.1% |
| SG&A Expenses | $34.3M-1.0% | $35.4M+5.0% | $34.4M+127.9% | $34.3M-61.6% | $34.7M-58.3% | $33.7M-58.1% | -$123.3M | $89.2M+19.6% |
| Operating Income | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $383.1M+18.9% |
| Interest Expense | $36.0M+3.3% | $34.0M-2.8% | $35.2M-1.3% | $36.1M+15.1% | $34.9M+11.1% | $35.0M+22.3% | $35.7M | $31.4M+20.9% |
| Income Tax | $67.1M+10.9% | $63.6M+3.4% | $63.4M+10.8% | $89.3M+20.7% | $60.5M-5.3% | $61.5M+1.3% | $57.2M | $74.0M+19.8% |
| Net Income | $287.7M+13.8% | $270.5M+6.3% | $266.1M+4.3% | $387.8M+28.0% | $252.7M-2.2% | $254.6M+0.1% | $255.2M-7.1% | $303.0M+17.9% |
| EPS (Basic) | $3.71+20.1% | $3.45+13.1% | $3.36+10.9% | $4.81+39.4% | $3.09+9.2% | $3.05+12.5% | $3.03+3.8% | $3.45+26.8% |
| EPS (Diluted) | $3.65+19.7% | $3.39+12.6% | $3.30+9.6% | $4.73+37.5% | $3.05+7.8% | $3.01+12.7% | $3.01+4.5% | $3.44+28.4% |
| Diluted Shares (Avg) | 79M-4.7% | 80M-5.6% | N/A | 82M-6.9% | 83M-9.5% | 84M-11.2% | N/A | 88M-8.1% |
Not reported in any period shown, so not listed: Cost of Revenue, R&D Expenses, EBITDA.
GL Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $31.6B+5.9% | $31.0B+4.2% | $30.8B+6.0% | $30.5B+3.3% | $29.8B+5.3% | $29.7B+4.0% | $29.1B+3.7% | $29.6B+12.7% |
| Cash & Equivalents | $257.1M+7.5% | $255.2M+9.9% | $144.7M-12.5% | $302.7M+125.0% | $239.1M+172.0% | $232.3M+178.0% | $165.3M+60.3% | $134.5M+57.3% |
| Short-Term Investments | $198.3M+69.9% | $183.8M+37.1% | $314.7M+270.1% | $62.8M-37.5% | $116.7M+16.1% | $134.1M+129.5% | $85.0M+4.0% | $100.5M+19.7% |
| Long-Term Investments | $1.5B+15.6% | $1.4B+16.0% | $1.4B+13.0% | $1.3B+5.2% | $1.3B+30.2% | $1.2B+37.5% | $1.2B+47.8% | $1.2B+16.4% |
| Goodwill | $490.4M0.0% | $490.4M0.0% | $490.4M0.0% | $490.4M0.0% | $490.4M+1.8% | $490.4M+1.8% | $490.4M+1.8% | $490.4M+1.8% |
| Total Liabilities | $25.4B+4.2% | $24.9B+2.5% | $24.8B+4.5% | $24.8B-0.3% | $24.4B+5.7% | $24.3B+3.2% | $23.8B+0.9% | $24.9B+15.4% |
| Long-Term Debt | $2.7B+14.6% | $2.3B-0.1% | $2.3B-0.1% | $2.3B-0.2% | $2.3B+42.6% | $2.3B+42.6% | $2.3B+42.6% | $2.3B+29.2% |
| Total Equity | $6.2B+13.6% | $6.1B+12.1% | $6.0B+12.6% | $5.7B+22.6% | $5.4B+3.7% | $5.4B+7.7% | $5.3B+18.2% | $4.6B+0.3% |
| Retained Earnings | $9.0B+6.9% | $8.8B+6.8% | $8.5B+6.8% | $8.8B+7.1% | $8.5B+6.4% | $8.2B+6.7% | $8.0B+7.0% | $8.2B+9.4% |
Not reported in any period shown, so not listed: Current Assets, Inventory, Accounts Receivable, Current Liabilities, Non-Current Liabilities.
GL Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $314.1M+2.0% | $420.9M-2.5% | $350.6M+4.1% | $306.0M-10.2% | $307.9M-17.7% | $431.9M+23.1% | $336.9M-13.9% | $340.6M+18.7% |
| Stock-Based Compensation | $17.0M+20.9% | $13.6M+13.2% | N/A | $14.6M+58.2% | $14.0M+39.2% | $12.0M+29.7% | N/A | $9.2M+22.0% |
| Capital Expenditures | $16.5M+27.5% | $24.9M+112.1% | $20.5M+36.7% | $97.3M+232.0% | $12.9M-26.6% | $11.7M+29.0% | $15.0M+14.5% | $29.3M+170.9% |
| Free Cash Flow | $297.6M+0.9% | $396.0M-5.7% | $330.1M+2.5% | $208.7M-33.0% | $295.0M-17.3% | $420.1M+23.0% | $321.9M-14.9% | $311.3M+12.8% |
| Investing Cash Flow | -$271.9M-324.6% | -$281.3M-17.2% | -$265.8M-246.6% | -$73.8M+62.4% | -$64.0M-160.8% | -$240.0M+67.2% | $181.4M+284.7% | -$196.3M+53.0% |
| Financing Cash Flow | -$48.1M+79.2% | -$29.6M+76.2% | -$241.0M+51.9% | -$171.8M-80.7% | -$230.8M+51.6% | -$124.5M-134.9% | -$501.0M-84.4% | -$95.1M-169.5% |
| Dividends Paid | $25.7M+14.8% | $21.4M+6.0% | $21.7M+7.3% | $21.9M+1.2% | $22.4M-0.8% | $20.1M-4.6% | $20.2M-4.6% | $21.6M+1.1% |
| Share Buybacks | $274.7M+9.8% | $240.5M-9.1% | $192.3M+272.2% | $173.9M-70.6% | $250.3M-25.5% | $264.5M+1027.2% | $51.7M-64.4% | $591.1M+510.0% |
Not reported in any period shown, so not listed: Depreciation & Amortization.
GL Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 26.1%+2.9pp |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 26.3%+3.0pp |
| Net Margin | 18.0%+0.9pp | 17.3%+0.2pp | 17.5%+0.1pp | 25.6%+4.8pp | 17.1%-0.9pp | 17.2%-0.8pp | 17.4%-2.0pp | 20.8%+2.2pp |
| Return on Equity | 4.7%0.0pp | 4.5%-0.2pp | 4.5%-0.4pp | 6.8%+0.3pp | 4.7%-0.3pp | 4.7%-0.4pp | 4.8%-1.3pp | 6.5%+1.0pp |
| Return on Assets | 0.9%+0.1pp | 0.9%0.0pp | 0.9%0.0pp | 1.3%+0.2pp | 0.9%-0.1pp | 0.9%0.0pp | 0.9%-0.1pp | 1.0%+0.1pp |
| Debt-to-Equity | 0.430.0x | 0.380.0x | 0.390.0x | 0.41-0.1x | 0.43+0.1x | 0.43+0.1x | 0.44+0.1x | 0.50+0.1x |
| Asset Turnover | 0.050.0x | 0.050.0x | 0.050.0x | 0.050.0x | 0.050.0x | 0.050.0x | 0.050.0x | 0.050.0x |
| FCF Margin | 18.6%-1.3pp | 25.4%-3.0pp | 21.7%-0.2pp | 13.8%-7.6pp | 19.9%-4.8pp | 28.4%+4.3pp | 22.0%-4.8pp | 21.4%+1.4pp |
Not reported in any period shown, so not listed: Current Ratio.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Globe Life Inc GL | FY2025 | $6.0B | $1.2B | 19.4% | $13.6B | 43/100 |
| Unum UNM | FY2025 | $13.1B | $738.5M | 5.7% | $14.7B | 29/100 |
| MetLife MET | FY2025 | $77.1B | $3.2B | 4.1% | $61.3B | 17/100 |
| Prudential Finl PRU | FY2025 | $60.8B | $3.6B | 5.9% | $41.3B | 11/100 |
| Lincoln Natl Corp Ind LNC | FY2025 | $18.2B | $1.2B | 6.5% | $8.4B | 19/100 |
| Aflac Inc AFL | FY2025 | $17.2B | $3.6B | 21.2% | $58.8B | 48/100 |
Where Globe Life Inc Ranks
Frequently Asked Questions
What is Globe Life Inc's annual revenue?
Globe Life Inc (GL) reported $6.0B in total revenue for fiscal year 2025. This represents a 3.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Globe Life Inc's revenue growing?
Globe Life Inc (GL) revenue grew by 3.7% year-over-year, from $5.8B to $6.0B in fiscal year 2025.
Is Globe Life Inc profitable?
Yes, Globe Life Inc (GL) reported a net income of $1.2B in fiscal year 2025, with a net profit margin of 19.4%.
How much debt does Globe Life Inc have?
As of fiscal year 2025, Globe Life Inc (GL) had $144.7M in cash and equivalents against $2.3B in long-term debt.
What is Globe Life Inc's net profit margin?
Globe Life Inc (GL) had a net profit margin of 19.4% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Does Globe Life Inc pay dividends?
Yes, Globe Life Inc (GL) paid $1.08 per share in dividends during fiscal year 2025.
What is Globe Life Inc's return on equity (ROE)?
Globe Life Inc (GL) has a return on equity of 19.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Globe Life Inc's free cash flow?
Globe Life Inc (GL) generated $1.3B in free cash flow during fiscal year 2025. This represents a -5.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Globe Life Inc's operating cash flow?
Globe Life Inc (GL) generated $1.4B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Globe Life Inc's total assets?
Globe Life Inc (GL) had $30.8B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Globe Life Inc's capital expenditures?
Globe Life Inc (GL) invested $142.5M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Globe Life Inc's debt-to-equity ratio?
Globe Life Inc (GL) had a debt-to-equity ratio of 0.39 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Globe Life Inc's return on assets (ROA)?
Globe Life Inc (GL) had a return on assets of 3.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Globe Life Inc's P/E ratio?
Globe Life Inc (GL) trades at 11.2x earnings, its market capitalization divided by net income of $1.2B net income, trailing 12 months to June 30, 2026. The market capitalization is $13.6B as of Sep 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Globe Life Inc's price-to-sales ratio?
Globe Life Inc (GL) trades at 2.2x sales, its market capitalization divided by revenue of $6.2B revenue, trailing 12 months to June 30, 2026. The market capitalization is $13.6B as of Sep 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Globe Life Inc's Piotroski F-Score?
Globe Life Inc (GL) has a Piotroski F-Score of 6 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Globe Life Inc's earnings high quality?
Globe Life Inc (GL) has an earnings quality ratio of 1.20x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Globe Life Inc?
Globe Life Inc (GL) scores 43 out of 100 on our Financial Health Score, indicating moderate standing within its insurers peer group. The score is a 0-100 composite of six dimensions (Loss Ratio, Premium Growth, Capital, Investment Yield, Combined Ratio, Stability), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.